FATE THERAPEUTICS INC Annual Share-based Payment Arrangement, Expense in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Fate Therapeutics Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2011 to 2023.
  • Fate Therapeutics Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $11.8M, a 16.4% increase year-over-year.
  • Fate Therapeutics Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $41.9M, a 21.6% decline year-over-year.
  • Fate Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2023 was $43.5M, a 44.8% decline from 2022.
  • Fate Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2022 was $78.7M, a 44.8% increase from 2021.
  • Fate Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2021 was $54.4M, a 76.8% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $43.5M -$35.3M -44.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 $78.7M +$24.4M +44.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 $54.4M +$23.6M +76.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $30.8M +$13.3M +76.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $17.4M +$11.1M +177% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $6.29M +$2.69M +74.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $3.61M +$422K +13.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $3.18M +$784K +32.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-05
2015 $2.4M -$34K -1.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-05
2014 $2.43M +$880K +56.6% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 $1.55M +$1.4M +903% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-03
2012 $155K -$17K -9.88% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 $172K Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.